
Explore the latest 8-K report from News Corporation, detailing significant events, stock classes, and insights for investors as of March 4, 2025.
Explore the latest 8-K report from News Corporation, detailing significant events, stock classes, and insights for investors as of March 4, 2025.
Discover crucial insights from News Corporation's March 2025 8-K filing, detailing stock classes and significant developments impacting shareholders.
Discover vital details from News Corporation's 8-K report, including stock information, corporate changes, and dual-class share insights for investors.
Explore News Corporation's latest 8-K filing from March 13, 2025, detailing stock classes, governance, and significant corporate events crucial for investors.
Explore Rush Enterprises, Inc.'s SEC 8-K filing dated February 18, 2025, detailing stock classes and compliance. Stay informed on significant corporate events.
Discover critical details from News Corporation's 8-K report filed on February 14, 2025. Explore stock classes, governance impacts, and corporate developments.
Explore News Corporation's February 2025 8-K report detailing stock classes, significant events, and corporate structure insights essential for investors and analysts.
Explore News Corporation's 8-K report filed on January 13, 2025, detailing stock classes and significant corporate events affecting investors. Key insights for stakeholders.
Explore Lennar Corp's latest 8-K filing dated January 10, 2025, revealing stock details, dual-class structure, and compliance with XBRL standards for improved investor transparency.
Explore News Corporation's 8-K filing detailing significant developments regarding Class A & B common stocks as of December 27, 2024. Key insights for investors!
Discover crucial insights from News Corporation's 8-K filing, detailing stock classes and significant events as of December 26, 2024.
Explore News Corporation's March 11, 2024 8-K filing, detailing its dual-class stock structure, governance, and important shareholder insights. Stay informed!